Immunocore Holdings Future Growth
Future criteria checks 1/6
Immunocore Holdings is forecast to grow earnings and revenue by 22.7% and 17.6% per annum respectively. EPS is expected to grow by 21.1% per annum. Return on equity is forecast to be -87.6% in 3 years.
Key information
22.7%
Earnings growth rate
21.1%
EPS growth rate
| Biotechs earnings growth | 24.7% |
| Revenue growth rate | 17.6% |
| Future return on equity | -87.6% |
| Analyst coverage | Good |
| Last updated | 06 Jun 2024 |
Recent future growth updates
Recent updates
Immunocore Holdings plc's (NASDAQ:IMCR) 28% Dip In Price Shows Sentiment Is Matching Revenues
Jun 16
Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?
May 11Immunocore Holdings plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 11Are Investors Undervaluing Immunocore Holdings plc (NASDAQ:IMCR) By 25%?
Apr 05Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money
Jan 22Immunocore Holdings: Vulnerable To Profit Taking After Big Rally
Jan 21Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%
Dec 18Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S
May 08Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically
Nov 16Immunocore: Attractive Commercial-Stage Biopharma
Oct 05Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)
Aug 12Immunocore GAAP EPS of -$0.17, revenue of $38.92M
Aug 10Immunocore to raise $140M in private placement financing
Jul 18Analysts Are Updating Their Immunocore Holdings plc (NASDAQ:IMCR) Estimates After Its Second-Quarter Results
Aug 15Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 356 | -136 | -85 | -13 | 12 |
| 12/31/2025 | 332 | -122 | -83 | -75 | 16 |
| 12/31/2024 | 304 | -103 | -38 | -29 | 16 |
| 3/31/2024 | 265 | -60 | -15 | -12 | N/A |
| 12/31/2023 | 249 | -55 | -2 | 3 | N/A |
| 9/30/2023 | 234 | -66 | 14 | 21 | N/A |
| 6/30/2023 | 231 | -63 | 20 | 26 | N/A |
| 3/31/2023 | 201 | -52 | -6 | -1 | N/A |
| 12/31/2022 | 174 | -53 | -51 | -49 | N/A |
| 9/30/2022 | 114 | -62 | -55 | -54 | N/A |
| 6/30/2022 | 82 | -112 | -96 | -94 | N/A |
| 3/31/2022 | 53 | -156 | -134 | -133 | N/A |
| 12/31/2021 | 36 | -180 | -144 | -143 | N/A |
| 9/30/2021 | 37 | -150 | -137 | -135 | N/A |
| 6/30/2021 | 39 | -139 | -111 | -110 | N/A |
| 3/31/2021 | 42 | -116 | -83 | -78 | N/A |
| 12/31/2020 | 41 | -101 | -88 | -84 | N/A |
| 9/30/2020 | 37 | -105 | -91 | -86 | N/A |
| 6/30/2020 | 34 | -109 | -137 | -131 | N/A |
| 3/31/2020 | 33 | -120 | -146 | -141 | N/A |
| 12/31/2019 | 34 | -138 | -142 | -136 | N/A |
| 12/31/2018 | 30 | -91 | -26 | -21 | N/A |
| 12/31/2017 | 19 | -66 | N/A | -82 | N/A |
| 12/31/2016 | 20 | -29 | N/A | -45 | N/A |
| 12/31/2015 | 17 | 20 | N/A | -26 | N/A |
| 9/30/2014 | 10 | -9 | N/A | 65 | N/A |
| 9/30/2013 | 3 | -6 | N/A | 18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IMCR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IMCR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IMCR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IMCR's revenue (17.6% per year) is forecast to grow faster than the US market (8.6% per year).
High Growth Revenue: IMCR's revenue (17.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IMCR is forecast to be unprofitable in 3 years.